14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Mar 28, 2024 $44.95 $44.95 $43.32 $43.35 1 904 913
Mar 27, 2024 $44.56 $44.85 $43.83 $44.66 849 705
Mar 26, 2024 $44.35 $44.75 $43.59 $44.11 882 535
Mar 25, 2024 $42.66 $43.99 $42.66 $43.91 846 101
Mar 22, 2024 $42.56 $42.93 $42.33 $42.72 752 488
Mar 21, 2024 $43.00 $43.97 $42.64 $42.75 642 602
Mar 20, 2024 $41.99 $42.80 $41.60 $42.78 539 753
Mar 19, 2024 $41.89 $42.68 $41.89 $42.16 967 637
Mar 18, 2024 $42.58 $42.78 $41.97 $42.03 853 933
Mar 15, 2024 $42.03 $42.62 $41.86 $42.55 1 080 263
Mar 14, 2024 $42.99 $43.12 $41.68 $42.18 1 280 944
Mar 13, 2024 $43.47 $43.95 $42.79 $43.16 1 075 086
Mar 12, 2024 $43.28 $43.38 $42.89 $43.17 798 887
Mar 11, 2024 $43.97 $44.64 $43.16 $43.26 955 380
Mar 08, 2024 $45.24 $45.40 $43.92 $43.99 1 013 811
Mar 07, 2024 $44.60 $45.00 $43.78 $44.67 976 548
Mar 06, 2024 $44.21 $44.80 $43.87 $44.29 930 339
Mar 05, 2024 $44.78 $45.15 $44.02 $44.19 814 318
Mar 04, 2024 $45.47 $45.51 $44.49 $44.87 1 088 779
Mar 01, 2024 $45.16 $46.10 $44.91 $45.46 1 451 613
Feb 29, 2024 $46.92 $47.08 $45.17 $45.21 1 202 035
Feb 28, 2024 $47.13 $47.66 $46.48 $46.54 1 087 126
Feb 27, 2024 $46.36 $47.62 $46.06 $47.41 1 881 411
Feb 26, 2024 $45.43 $46.39 $45.14 $46.10 1 391 278
Feb 23, 2024 $44.09 $45.39 $44.02 $45.36 1 666 873
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT